STAAR Surgical to Present at UBS Global Life Sciences Conference
MONROVIA, Calif., Sept. 5 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will present at the UBS Global Life Sciences Conference, which will take place at the Grand Hyatt in New York City on Thursday, September 28th, 2006. The Company is scheduled to discuss its business strategy and historical financial performance at 12:00 PM Eastern Time.
Attendance at the conference is by invitation only. A live audio-only webcast of STAAR's presentation may be accessed through the Company's website at www.staar.com . An archived replay of the presentation will be available approximately 3 hours after the live presentation and can also be accessed at www.staar.com .
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR's ICL is approved by the FDA for use in treating myopia, has received CE Marking and is approved for sale in 43 countries. More than 50,000 ICLs have been sold worldwide. Collamer(R) is a registered trademark for STAAR's proprietary collagen co-polymer lens material. More information is available at www.staar.com .
CONTACT: Investors Media EVC Group EVC Group Douglas Sherk, 415-896-6820 Jen Saunders, 646-277-8720 Jennifer Beugelmans, 646-277-8704 SOURCE STAAR Surgical Company -0- 09/05/2006 /CONTACT: media, Jen Saunders, +1-646-277-8720, or investors, Douglas Sherk, +1-415-896-6820, or Jennifer Beugelmans, +1-646-277-8704, all of EVC Group, for STAAR Surgical/ /Web site: http://www.staar.com/ (STAA) CO: STAAR Surgical Company ST: California, New York IN: MTC HEA SU: TDS SF-ND -- SFTU032 -- 8734 09/05/2006 06:00 EDT http://www.prnewswire.com